C12N 2760/16111
Influenzavirus a, i.e. influenza a virus
Official title: Influenzavirus A, i.e. influenza A virus
C12N2760/16111 (Influenzavirus a, i.e. influenza a virus) appears on 2,000 US grants and 3,168 published applications in this corpus.
Search patents in C12N- Granted patents
- 2,000
- Published applications
- 3,168
- Assignees
- 1,225
- Inventors
- 4,877
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 3 | 0 |
| 1978 | 3 | 0 |
| 1979 | 3 | 0 |
| 1980 | 6 | 0 |
| 1981 | 2 | 0 |
| 1982 | 5 | 0 |
| 1983 | 0 | 0 |
| 1984 | 3 | 0 |
| 1985 | 6 | 0 |
| 1986 | 4 | 0 |
| 1987 | 6 | 0 |
| 1988 | 5 | 0 |
| 1989 | 4 | 0 |
| 1990 | 1 | 0 |
| 1991 | 4 | 0 |
| 1992 | 7 | 0 |
| 1993 | 2 | 0 |
| 1994 | 5 | 0 |
| 1995 | 3 | 0 |
| 1996 | 15 | 0 |
| 1997 | 25 | 0 |
| 1998 | 40 | 0 |
| 1999 | 27 | 0 |
| 2000 | 30 | 0 |
| 2001 | 35 | 7 |
| 2002 | 25 | 30 |
| 2003 | 25 | 68 |
| 2004 | 26 | 74 |
| 2005 | 18 | 58 |
| 2006 | 17 | 66 |
| 2007 | 27 | 92 |
| 2008 | 30 | 87 |
| 2009 | 52 | 133 |
| 2010 | 44 | 160 |
| 2011 | 52 | 159 |
| 2012 | 59 | 164 |
| 2013 | 87 | 157 |
| 2014 | 100 | 172 |
| 2015 | 117 | 133 |
| 2016 | 114 | 160 |
| 2017 | 110 | 162 |
| 2018 | 127 | 155 |
| 2019 | 128 | 152 |
| 2020 | 115 | 134 |
| 2021 | 92 | 124 |
| 2022 | 87 | 153 |
| 2023 | 81 | 144 |
| 2024 | 84 | 199 |
| 2025 | 84 | 130 |
| 2026 | 47 | 95 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2760/16134Use of virus or viral component as vaccineIndexing code1,554
- C12N 2760/16122New viral proteins or individual genes, new structural or functional aspects ofIndexing code869
- C12N 2760/16151Methods of production or purification of viral materialIndexing code330
- C12N 2760/16161Methods of inactivation or attenuationIndexing code219
- C12N 2760/16171Demonstrated in vivo effectIndexing code211
- C12N 2760/16121Viruses as suchIndexing code158
- C12N 2760/16123Virus like particles [vlp]Indexing code122
- C12N 2760/16141Use of virus, viral particle or viral elements as a vectorIndexing code101
All 12 subgroupsShow fewer
Recent patents
- Virus-like particles containing CST1 protein and toxoplasma vaccine using same1 Sep 2026US 12,721,886 B2University-Industry Cooperation Group of Kyung Hee University
- Coronavirus and influenza compositions and methods for using them25 Aug 2026US 12,714,744 B2
- Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)25 Aug 2026US 12,714,745 B2Baylor Research Institute
- Method for prevention and treatment of viral disease25 Aug 2026US 12,714,746 B2Morehouse School of Medicine
- Influenza virus encoding a truncated NS1 protein and a SARS-CoV receptor binding domain18 Aug 2026US 12,708,663 B2Vivaldi Biosciences Inc.
- Influenza ehead immunogens1 Oct 2026US 2026/0295029 A1The Scripps Research Institute
- Universal avian flu vaccine (aiv)1 Oct 2026US 2026/0297137 A1DEI Biopharma
- Influenza virus vaccines24 Sep 2026US 2026/0284174 A1Glaxosmithkline Biologicals SA
- Immunogenic compositions against influenza and rsv17 Sep 2026US 2026/0273040 A1Pfizer Inc.
- Broadly reactive viral antigens as immunogens, compositions and methods of use thereof17 Sep 2026US 2026/0273041 A1University of Georgia Research Foundation, Inc.
Most cited
By later US patents
- Modified vaccinia virus298US 4,603,112 AHealth Research, Inc. · 1986
- Modified vaccinia virus and methods for making and using the same264US 4,769,330 AHealth Research, Inc. · 1988
- Composition for introducing nucleic acid complexes into higher eucaryotic cells257US 5,547,932 ABoehringer Ingelheim International GmbH · 1996
- Method for immunizing animals with synthetically modified vaccinia virus240US 4,722,848 AHealth Research, Inc. · 1988
- Recombinant negative strand RNA virus expression-systems218US 5,166,057 AMount Sinai School of Medicine of the City University of New York · 1992